Preparation of curcumin micelles and the in vitro and in vivo evaluation for cancer therapy

Journal of Biomedical Nanotechnology

Volumn 10, Issue 8, 2014, Pages 1458-1468

  Li, Xingyi ^a   Chen, Tongke ^a   Xu, Lu ^a   Zhang, Zhaoliang ^a   Li, Lingli ^a   Chen, Hao ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Anti Tumor; Curcumin; In vitro; In vivo; Micelles; West blot

Indexed keywords

BIOCHEMISTRY; CELL CULTURE; CELL DEATH; CELL ENGINEERING; MAMMALS; ONCOLOGY; SOLUBILITY; SPECTRUM ANALYSIS; TUMORS;

ANTI-TUMORS; CURCUMIN; IN-VITRO; IN-VIVO; WEST BLOT;

MICELLES;

CASPASE 9; CURCUMIN; PHOSPHATE BUFFERED SALINE; POLOXAMER; PROTEIN BCL 2; PROTEIN KINASE B; RETINOBLASTOMA PROTEIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL LINE; CANCER THERAPY; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DOWN REGULATION; DRUG BIOAVAILABILITY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG FORMULATION; DRUG INHIBITION; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; ENZYME ACTIVATION; FLUORESCENCE SPECTROSCOPY; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PROTEIN EXPRESSION; TUMOR XENOGRAFT; WESTERN BLOTTING; X RAY DIFFRACTION;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BODY WEIGHT; CELL LINE, TUMOR; CURCUMIN; DRUG STABILITY; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICELLES; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; SOLUBILITY;

EID: 84899684594     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1840     Document Type: Article

References (40)

1. S. Fulda, L. Galluzzi, and G. Kroemer, Targeting mitochondria for cancer therapy. Nat. Rev. Drug Discov. 9, 447 (2010).
2. S. Dhar, N. Kolishetti, S. J. Lippard, and O. C. Farokhzad, Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. P. Natl. Acad Sci. USA 108, 1850 (2011).
3. T. A. Moore, A. M. Berger, and P. Dizona, Sleep aid use during and following breast cancer adjuvant chemotherapy. Psycho-Oncology 20, 321 (2011).
4. N. Sanoj Rejinold, M. Muthunarayanan, K. P. Chennazhi, S. V. Nair, and R. Jayakumar, Curcumin loaded fibrinogen nanoparticles for cancer drug delivery. J. Biomed. Nanotechnol. 7, 521 (2011).
5. G. Zhang, X. Zeng, and P. Li, Nanomaterials in cancer-therapy drug delivery system. J. Biomed. Nanotechnol. 9, 741 (2013).
6. K. Cho, X. Wang, S. Nie, and D. M. Shin, Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 14, 1310 (2008).
7. S. Vinogradov and X. Wei, Cancer stem cells and drug resistance: The potential of nanomedicine. Nanomedicine 7, 597 (2012).
8. M. A. Kohanski, M. A. DePristo, and J. J. Collins, Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol. Cell 37, 311 (2010).
9. M. M. Yallapu, M. Jaggi, and S. C. Chauhan, Curcumin nanoformulations: A future nanomedicine for cancer. Drug Discov. Today 17, 71 (2012).
10. M. Sun, X. Su, B. Ding, X. He, X. Liu, A. Yu, H. Lou, and G. Zhai, Advances in nanotechnology-based delivery systems for curcumin. Nanomedicine-UK 7, 1085 (2012).
11. A. S. Darvesh, B. B. Aggarwal, and A. Bishayee, Curcumin and liver cancer: A review. Curr. Pharm. Biotechno. 13, 218 (2012).
12. C. Gong, Q. Wu, Y. Wang, D. Zhang, F. Luo, X. Zhao, Y. Wei, and Z. Qian, A biodegradable hydrogel system containing curcumin encapsulated in micelles for cutaneous wound healing. Biomaterials 34, 6377 (2013).
13. M. L. Gou, K. Men, H. S. Shi, M. L. Xiang, J. Zhang, J. Song, J. L. Long, Y. Wan, F. Luo, and X. Zhao, Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale 3, 1558 (2012).
14. H. Tang, C. J. Murphy, B. Zhang, Y. Shen, M. Sui, E. A. Van Kirk, X. Feng, and W. J. Murdoch, Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers: In vitro and in vivo effects. Nanomedicine 5, 855 (2010).
15. C. Gong, S. Deng, Q. Wu, M. Xiang, X. Wei, L. Li, X. Gao, B. Wang, L. Sun, and Y. Chen, Improving antiangiogenesis and antitumor activity of curcumin by biodegradable polymeric micelles. Biomaterials 34, 1413 (2013).
16. A. Sahebkar, Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? BioFactors 39, 197 (2013).
17. N. Suwannateep, W. Banlunara, S. P. Wanichwecharungruang, K. Chiablaem, K. Lirdprapamongkol, and J. Svasti, Mucoadhesive curcumin nanospheres: Biological activity, adhesion to stomach mucosa and release of curcumin into the circulation. J. Control Release 151, 176 (2011).
18. N. Dhillon, B. B. Aggarwal, R. A. Newman, R. A. Wolff, A. B. Kunnumakkara, J. L. Abbruzzese, C. S. Ng, V. Badmaev, and R. Kurzrock, Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 14, 4491 (2008).
19. J. Cui, B. Yu, Y. Zhao, W. Zhu, H. Li, H. Lou, and G. Zhai, Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int. J. Pharm. 371, 148 (2009).
20. N. S. Rejinold, P. R. Sreerekha, K. P. Chennazhi, S. V. Nair, and R. Jayakumar, Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly(N-isopropylacrylamide) nanocarrier for curcumin drug delivery. Int. J. Biol. Macromol. 49, 161 (2011).
21. M. M. Yallapu, M. Jaggi, and S. C. Chauhan, β-cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloid. Surface. B 79, 113 (2010).
22. N. Sanoj Rejinold, M. Muthunarayanan, V. V. Divyarani, P. R. Sreerekha, K. P. Chennazhi, S. V. Nair, H. Tamura, and R. Jayakumar, Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery. J. Colloid Interf. Sci. 360, 39 (2011).
23. X. Y. Li, K. Nan, L. Li, Z. Zhang, and H. Chen, In vivo evaluation of curcumin nanoformulation loaded methoxy poly(ethylene glycol)-graft-chitosan composite film for wound healing application. Carbohyd. Polym. 88, 84 (2012).
24. P. Anand, H. B. Nair, B. Sung, A. B. Kunnumakkara, V. R. Yadav, R. R. Tekmal, and B. B. Aggarwal, Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem. Pharmacol. 79, 330 (2010).
25. C. Yang, L. Jiang, S. Bu, L. Zhang, X. Xie, Q. Zeng, D. Zhu, and Y. Zheng, Intravitreal administration of dexamethasone-loaded PLGA-TPGS nanoparticles for the treatment of posterior segment diseases. J. Biomed. Nanotechnol. 9, 1617 (2013).
26. R. Surolia, M. Pachauri, and P. C. Ghosh, Preparation and characterization of monensin loaded PLGA nanoparticles: In vitro anti-malarial activity against plasmodium falciparum. J. Biomed. Nanotechnol. 8, 172 (2012).
27. Y. M. Tsai, C. F. Chien, L. C. Lin, and T. H. Tsai, Curcumin and its nano-formulation: The kinetics of tissue distribution and blood brain barrier penetration. Int. J. Pharm. 416, 331 (2011).
28. C. Mohanty and S. K. Sahoo, The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 31, 6597 (2010).
29. A. V. Kabanov, E. V. Batrakova, and V. Y. Alakhov, Pluronic® block copolymers for overcoming drug resistance in cancer. Adv. Drug Deliv. Rev. 54, 759 (2002).
30. C. Mohanty, S. Acharya, A. K. Mohanty, F. Dilnawaz, and S. K. Sahoo, Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: A novel controlled delivery vehicle for cancer therapy. Nanomedicine 5, 433 (2010).
31. K. Shahani, S. K. Swaminathan, D. Freeman, A. Blum, L. Ma, and J. Panyam, Injectable sustained release microparticles of curcumin: A new concept for cancer chemoprevention. Cancer Res. 70, 4443 (2010).
32. O. C. Farokhzad and R. Langer, Impact of nanotechnology on drug delivery. ACS Nano 3, 16 (2009).
33. K. Letchford and H. Burt, A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur. J. Pharm. Biopharm. 65, 259 (2007).
34. W. R. Sanhai, J. H. Sakamoto, R. Canady, and M. Ferrari, Seven challenges for nanomedicine. Nature Nanotechnol. 3, 242 (2008).
35. D. A. Chiappetta and A. Sosnik, Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs. Eur. J. Pharm Biopharm. 66, 303 (2007).
36. M. L. Gou, M. Dai, X. Y. Li, X. H. Wang, C. Y. Gong, Y. Xie, K. Wang, X. Zhao, Z. Y. Qian, and Y. Q. Wei, Preparation and characterization of honokiol nanoparticles. J. Mater. Sci.: Mater. Med. 19, 2605 (2008).
37. N. R. Jana, P. Dikshit, A. Goswami, and N. Nukina, Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J. Biol. Chem. 279, 11680 (2004).
38. A. Lujambio, S. Ropero, E. Ballestar, M. F. Fraga, C. Cerrato, F. Setin, S. Casado, A. Suarez-Gauthier, M. Sanchez-Cespedes, and A. Gitt, Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67, 1424 (2007).
39. C. Chang and Z. Werb, The many faces of metalloproteases: Cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol. 11, S37 (2001).
40. M. Szkudlarek, R. M. Bosio, Q. Wu, and K.-V. Chin, Inhibition of angiogenesis by extracellular protein kinase A. Cancer Lett. 283, 68 (2009).